World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
51374
World Ranking
4342
National Ranking
133

Alberto Papi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alberto Papi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 652 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alberto Papi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alberto Papi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alberto Papi is affiliated with the University of Ferrara in Italy and specializes in the field of Medicine with a concentrated focus on pulmonary and respiratory medicine. Their research contributions span multiple subfields, including Physiology, Epidemiology, Immunology, and Infectious Diseases.

The scientist's work centers around several main topics, such as:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Respiratory Support and Mechanisms
  • IL-33, ST2, and ILC Pathways
  • Respiratory viral infections research

Alberto Papi has been a frequent contributor to prominent scientific journals, with multiple publications in venues such as:

  • American Journal of Respiratory and Critical Care Medicine
  • European Respiratory Journal
  • Allergy
  • CHEST Journal
  • Journal of Allergy and Clinical Immunology

The scientist's notable recent papers include:

  • Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults, 2023, New England Journal of Medicine
  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, European Respiratory Journal
  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, American Journal of Respiratory and Critical Care Medicine
  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease, 2020, American Journal of Respiratory and Critical Care Medicine
  • Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision, 2022, American Journal of Respiratory and Critical Care Medicine

Collaboration has been a significant aspect of Alberto Papi's research activities. Frequent co-authors include:

  • Dave Singh
  • Ian Pavord
  • Marco Contoli
  • Klaus F. Rabe
  • Claus Vogelmeier

In addition to journal publications, Alberto Papi has contributed to book literature in the field. The European Respiratory Society published a book authored by Papi entitled Anti-inflammatory reliever therapy, scheduled for 2025.

Best Publications

  • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

    Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes

  • First result from the Alpha Magnetic Spectrometer on the International Space Station: precision measurement of the positron fraction in primary cosmic rays of 0.5-350 GeV.

    M Aguilar;G Alberti;B Alpat;A Alvino

  • Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

    Eugene R Bleecker;J Mark FitzGerald;Pascal Chanez;Alberto Papi

  • Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.

    Alberto Papi;Cinzia Maria Bellettato;Fausto Braccioni;Micaela Romagnoli

  • Role of deficient type III interferon-λ production in asthma exacerbations

    Marco Contoli;Simon D Message;Vasile Laza-Stanca;Michael R Edwards

  • The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

    B Abraham;JM Anto;E Barreiro;Ehd Bel

  • Electron and Positron Fluxes in Primary Cosmic Rays Measured with the Alpha Magnetic Spectrometer on the International Space Station

    M. Aguilar;D. Aisa;A. Alvino;G. Ambrosi

  • Rhinoviruses Infect the Lower Airways

    Nikolaos G. Papadopoulos;Philip J. Bates;Philip G. Bardin;Alberto Papi

  • Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease

    Leonardo M. Fabbri;Micaela Romagnoli;Lorenzo Corbetta;Gianluca Casoni

  • The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics

    Paola Panina-Bordignon;Alberto Papi;Margherita Mariani;Pietro Di Lucia

  • Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

    Jadwiga A. Wedzicha;Marc Miravitlles;John R. Hurst;Peter M.A. Calverley

  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

    David M G Halpin;Gerard J Criner;Alberto Papi;Dave Singh

  • Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.

    Alberto Papi;Jørgen Vestbo;Leonardo Fabbri;Leonardo Fabbri;Massimo Corradi

  • Increased Expression of the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease

    Marina Saetta;Margherita Mariani;Paola Panina-Bordignon;Graziella Turato

  • An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease

    Bartolome R. Celli;Marc Decramer;Jadwiga A. Wedzicha;Kevin C. Wilson

  • Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription *

    Alberto Papi;Sebastian L. Johnston

  • Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

    Dave Singh;Alberto Papi;Massimo Corradi;Ilona Pavlišová

  • Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.

    Jørgen Vestbo;Jørgen Vestbo;Alberto Papi;Massimo Corradi;Viktor Blazhko

  • Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.

    Simon D. Message;Vasile Laza-Stanca;Patrick Mallia;Hayley L. Parker

  • T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients

    A. Di Stefano;G. Caramori;I. Gnemmi;M. Contoli

Frequent Co-Authors

Leonardo M. Fabbri
Leonardo M. Fabbri University of Ferrara
Sebastian L. Johnston
Sebastian L. Johnston Imperial College London
Marina Saetta
Marina Saetta University of Padua
Dave Singh
Dave Singh University of Manchester
Ian M. Adcock
Ian M. Adcock Imperial College London
Ian D. Pavord
Ian D. Pavord University of Oxford
David Price
David Price University of Aberdeen
Jørgen Vestbo
Jørgen Vestbo University of Manchester
Kian Fan Chung
Kian Fan Chung Imperial College London
Peter J. Barnes
Peter J. Barnes Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens several alternative pathways in healthcare, especially for those seeking flexibility or an accelerated timeline. Online programs have evolved, offering both speed and convenience for aspiring practitioners and nurses.

If you’re looking for the fastest route to higher nursing qualifications, accelerated dnp programs provide an intensive curriculum to help you complete your Doctor of Nursing Practice efficiently. For those concerned about clinical requirements, there are also online dnp programs without clinicals, making career advancement more accessible for working professionals.

Prospective healthcare workers can also explore fast track medical programs that allow students to become Licensed Practical Nurses (LPNs) in less time than traditional routes. Alternatively, mental health nursing is in high demand, and the fastest pmhnp program options can prepare you for advanced psychiatric practice in a shorter time frame.

These programs can provide a quicker, more flexible route to enter or advance in the healthcare sector, allowing you to tailor your educational journey to your career goals.

Best Scientists Citing Alberto Papi

Trending Scientists

Recently Published Articles